SCHEMBL7356240

SCHEMBL7356240

CCCn1c(N)c(N=O)c(=O)n(CCC)c1=O

nearest known ligand 0.47

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 1/20 0.47
LMNA P02545 1/20 0.47
NPSR1 Q6W5P4 1/20 0.44
CASP6 P55212 1/20 0.43
ADORA2B P29275 6/20 0.41
PDE4A P27815 5/20 0.41
PDE4B Q07343 5/20 0.41
PDE4C Q08493 5/20 0.41
PDE4D Q08499 5/20 0.41
ADORA2A P29274 5/20 0.41
CYP1A2 P05177 1/20 0.39
CYP3A4 P08684 1/20 0.39
BLM P54132 1/20 0.39
PMP22 Q01453 1/20 0.39
HSD17B10 Q99714 1/20 0.39
ADORA1 P30542 1/20 0.37
SMN1; SMN2 Q16637 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL242052 0.93 ALDH1A1 (0.41) ALDH1A1LMNANPSR1CASP6ADORA2B
SCHEMBL13746372 0.92 PDE4A (0.43) ALDH1A1LMNANPSR1CASP6ADORA2B
SCHEMBL7743865 0.90 PDE4A (0.42) ALDH1A1LMNANPSR1CASP6ADORA2B
SCHEMBL1546702 0.88 CASP6 (0.50) ALDH1A1LMNANPSR1CASP6ADORA2B
SCHEMBL7321137 0.88 CASP6 (0.50) ALDH1A1LMNANPSR1CASP6ADORA2B
SCHEMBL8873522 0.83 ALDH1A1 (0.49) ALDH1A1LMNAADORA2BADORA2ACYP3A4
SCHEMBL13753866 0.82 ADORA2B (0.40) ALDH1A1LMNACASP6ADORA2BPDE4A
SCHEMBL7781030 0.82 PDE5A (0.48) ADORA2BPDE4APDE4BPDE4CPDE4D
SCHEMBL3239986 0.82 NPSR1 (0.52) ALDH1A1LMNANPSR1ADORA2BADORA2A
SCHEMBL9729840 0.82 ALDH1A1 (0.45) ALDH1A1LMNAHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-1041418-C Xanthine derivatives as adenosine A1 receptor antagonists MERRELL DOW PHARMA (US) 1998-12-30 CN disclosed
US-5840729-A ATTENUATING COGNITIVE DEFICIT MERRELL PHARMACEUTICALS INC. (US) 1998-11-24 US disclosed
US-5734052-A HYPOTENSIVE AGENTS, SEDATIVES, ANTISPASMODIC AGENTS AND VASODILATORS MERRELL PHARMACEUTICALS INC. (US) 1998-03-31 US disclosed
US-5641784-A ADENOSINE ANTAGONISTS; TREATMENT OF NERVOUS SYSTEM DISORDERS, ALZHEIMER'S DISEASE BOEHRINGER INGELHEIM KG (DE) 1997-06-24 US disclosed
EP-0697020-A1 8-SUBSTITUTED XANTHINES AS SELECTIVE ADENOSINE RECEPTOR AGENTS MERRELL PHARMACEUTICALS INC. (US) 1996-02-21 EP disclosed
EP-0686155-A1 XANTHINE DERIVATIVES AS ADENOSINE A1 RECEPTOR ANTAGONISTS MERRELL PHARMACEUTICALS INC. (US) 1995-12-13 EP disclosed
WO-1994026744-A1 8-SUBSTITUTED XANTHINES AS SELECTIVE ADENOSINE RECEPTOR AGENTS MERRELL DOW PHARMACEUTICALS INC. (US) 1994-11-24 WO disclosed
WO-1994019349-A1 XANTHINE DERIVATIVES AS ADENOSINE A1 RECEPTOR ANTAGONISTS MERRELL DOW PHARMACEUTICALS INC. (US) 1994-09-01 WO disclosed
EP-0487673-A1 NEW XANTHINE DERIVATIVES BOEHRINGER INGELHEIM INTERNATIONAL GmbH (DE) 1992-06-03 EP disclosed
WO-1992007852-A1 BIPHENYLALKYL XANTHINE COMPOUNDS FOR TREATMENT OF CARDIOVASCULAR DISORDERS G.D. SEARLE & CO. (US) 1992-05-14 WO disclosed
WO-1992000297-A1 NEW XANTHINE DERIVATIVES BOEHRINGER INGELHEIM KG (DE) 1992-01-09 WO disclosed
US-5047534-A Xanthine derivatives; hyupotensive agents, cardiotonic agents MERRELL DOW PHARMACEUTICALS INC. (US) 1991-09-10 US disclosed
US-4769377-A Adenosine receptor antagonists THE JOHNS HOPKINS UNIVERSITY (US) 1988-09-06 US disclosed
US-4593095-A ADENOSINE RECEPTOR ANTAGONISTS THE JOHNS HOPKINS UNIVERSITY (US) 1986-06-03 US disclosed
US-4581451-A ALKYLATION AND CYCLIZATION OF A URACIL COMPOUND NESTEC S.A. (CH) 1986-04-08 US disclosed
EP-0039780-B1 DI- OR TRISUBSTITUTED XANTHINES WITH NEUROLEPTIC ACTIVITY, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL PREPARATIONS CONTAINING THEM SOCIETE DES PRODUITS NESTLE S.A. (CH) 1985-04-10 EP disclosed
US-4469698-A SEDATIVES, TRANQUILIZERS SOCIETE D'ASSISTANCE TECHNIQUE POUR PRODUITS NESTLE S.A. (CH) 1984-09-04 US disclosed
EP-0039780-A1 Di- or trisubstituted xanthines with neuroleptic activity, process for their preparation and pharmaceutical preparations containing them SOCIETE DES PRODUITS NESTLE S.A. (CH) 1981-11-18 EP disclosed